BUSINESS
COVID-19 vaccine: Premas Biotech initiates mice studies
The company said it had successfully completed the manufacturing process for the VLP (virus like particle) vaccine candidate, which includes three surface antigens from SARS-CoV-2.
BUSINESS
Japanese drugmaker Takeda launches gastrointestinal drug Vedolizumab in India
Kynteles which is sold globally as Entyvio in more than 60 countries, generated sales of $3.2 billion in FY20.
BUSINESS
Johnson & Johnson cuts price of TB drug Bedaquiline by 32%
The World Health Organisation (WHO) recommends the oral drug Bedaquiline as the backbone of DR-TB treatment, to replace older, more toxic drugs that have to be injected daily and can cause intolerable side effects, such as deafness
BUSINESS
First batch of Cipla's Remdesivir leaves contract manufacturer's site in Daman
Sovereign Pharma has the capacity to scale up production up to 95,000 vials per month
BUSINESS
Why top scientist Gagandeep Kang's sudden exit raises eyebrows?
Kang cited ‘personal reasons’ for her resignation, and dismissed speculation linking her resignation with government disbanding a committee headed by her to look into indigenous COVID-19 drugs and vaccines
BUSINESS
Hetero facilitates COVID-19 patients to access their remdesivir version
Patients who are in need of the drug will have to fill details such as Name, email, location, contact, number, and quantity, provided on the product enquiry page on Hetero website.
BUSINESS
Exclusive: COVID-19 drug Remdesivir in short supply, prices go up by 6x in black market
While Cipla's drug is yet to be available in the market, Hetero's initial supply of 20,000 vials is nearly exhausted.
BUSINESS
Pharma wrap: Why ICMR's Aug 15 deadline for COVID-19 vaccine launch is controversial
Vaccine experts raised serious concerns, calling the timelines unprecendented and unrealistic.
BUSINESS
Explained: How did Bharat Biotech emerge as dark horse in race for COVID-19 vaccine?
ICMR and Bharat Biotech are jointly working on the pre-clinical as well as clinical development of the vaccine.
BUSINESS
Chinese raw materials stuck at customs: Government tells pharma companies it will clear stocks
Imported raw materials such as intermediates and active pharmaceutical ingredients (APIs) from China are integral components in India's drug supply chain.
BUSINESS
Bharat Biotech's COVID-19 vaccine gets DCGI nod to conduct human trials
Bharat Biotech is developing COVID-19 vaccine in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV), Pune.
BUSINESS
COVID-19 vaccine demand | Have sufficient vials capacity: Companies
Health experts globally are concerned whether there would be enough glass-vials available to pack billion of COVID-19 vaccine doses.
BUSINESS
Social distancing, wearing face masks need to be pushed with vigour as COVID-19 cases rise
As COVID-19 cases continue to rise in India, social distancing and practice of wearing a mask in public need to be enforced with vigour.
BUSINESS
Piramal says Carlyle proceeds will help fund pharma acquisitions, organic growth
The company said it is looking at a range of pharma assets in India and abroad that include branded formulations, manufacturing sites, complex hospital generics and even possibly entering vaccines.
BUSINESS
Thermo Fisher Scientific ramping up COVID-19 test kits capacity, reopens Indian factories
scaled up global production of RT-PCR test kits from 50 thousand to 10 million a week.
BUSINESS
Cipla-BDR Pharmaceuticals eyeing early approval of Favipiravir
Both companies have given a commitment to conduct clinical trials and submit data, following approval
BUSINESS
Patanjali COVID-19 'cure' Coronil: Experts ask company to come clean on clinical trials, provide data
Patanjali has to provide clinical trial data and also share details of when and where trials were conducted, say experts.
BUSINESS
Johnson & Johnson exits fairness cream market, but what about competitors?
The Indian fairness cream market was worth about $450 million in 2019 which is largely dominated by Hindustan Unilever, Procter & Gamble and Garnier (L’Oréal).
BUSINESS
Why India needs to reassess use of HCQ for COVID-19 treatment
India has been using hydroxychloroquine, commonly known as HCQ, for treatment of COVID-19 patients and as prophylactic in high-risk groups such as healthcare and other frontline workers.
BUSINESS
COVID-19 treatment | Indian companies begin exports of Favipiravir, but wait for approval in India
Sources told Moneycontrol that Glenmark's Favipiravir is expected to get approval from drug regulator any moment, based on the intermediate data from the clinical trials given the urgency of the situation
BUSINESS
Mental Health Series Part 3: Is India Inc sensitive towards employees battling mental health issues?
With mental health still poorly understood in India, Indian companies have a lot of gap to bridge when it comes to sensitivity towards employee's psychological conditions.
BUSINESS
No shortage of dexamethasone in India, Chinese raw materials remain key
Sources within Zydus Cadila told Moneycontrol that the company has enough capacity to meet domestic need
BUSINESS
Mental Health Series Part 2: At up to Rs 19,000 for therapy, how many in India can afford treatment?
Amidst a renewed focus on mental health issues after actor Sushant Singh Rajput’s death by suicide, it is a reality that treatment for anxiety, depression and allied issues is unaffordable in India.
BUSINESS
Mental health series Part-1 | Sushant Singh Rajput’s death: Depression and role of COVID-19 in increasing psychological problems
Suicide is an extreme manifestation of mental health problem and is considered as a grey area medically. Even psychiatrists find it difficult to identify a suicidal person beforehand.
